Mapsepicin 10mg Injection
Marketer
AMPS Biotech Pvt Ltd
Salt Composition
Epirubicin (10mg)
Overview Mapsepicin 10mg Injection
Mapsepicin 10mg injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a medical professional, it's used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician, based on your condition and may vary. Strict adherence to prescribed instructions is crucial; improper usage can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under your doctor's guidance. Reliable contraception is advised for both genders as Mapsepicin reduces contraceptive pill effectiveness. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. It can lower blood cell counts, increasing infection risk, which may be life-threatening. Regular blood tests monitoring blood cell levels, kidney, liver, and heart function are necessary. Prior to commencing treatment, disclose any liver or heart conditions, and list all other medications, as interactions can affect Mapsepicin's efficacy or action. Inform your doctor if you are pregnant or nursing.
Uses of Mapsepicin 10mg Injection
Malignant neoplasm
Major Benefits of Mapsepicin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mapsepicin 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Mapsepicin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mapsepicin 10mg Injection works:
Oncaspar 10mg Injection is a medication used in the treatment of breast cancer. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage and subsequent cell death, thereby hindering tumor progression.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mapsepicin 10mg Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Mapsepicin 10mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Mapsepicin 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Mapsepicin 10mg Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Mapsepicin 10mg Injection, may temporarily compromise safe driving.
KidneySAFE IF PRESCRIBED
Mapsepicin 10mg Injection appears to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, a reduced dosage should be explored with a physician.
LiverCAUTION
Patients with liver impairment should receive Mapsepicin 10mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Mapsepicin 10mg Injection is contraindicated in individuals with advanced hepatic dysfunction.
What if you forget to take Mapsepicin 10mg Injection :
NA
Facts to Know About Mapsepicin 10mg Injection
| Label | Value |
|---|---|
| Type of Compound | Anthracycline-based drug |
| Potential for Dependence | None. |
| Type of Medication | Cancer treatments |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently